2006 Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

Volume 10, 2006 CD
Six back issues from 2006 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 10 No. 1	January/February 2006	Sports Medicine
Vol. 10 No. 2	March/April 2006	Hospice/Palliative Care
Vol. 10 No. 3	May/June 2006	Hormone Replacement Therapy
Vol. 10 No. 4	July/August 2006	Sterile Preparations
Vol. 10 No. 5	September/October 2006	Dermatology
Vol. 10 No. 6	November/December 2006	Veterinary Compounding

Volume 10, 2006 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 10, 2006 CD ARTICLES
PreScription: A Decade of IJPC	Vol. 10 No. 1	2
CompoundingToday.com: Literature, Book Reviews, & More	Vol. 10 No. 1	5
Compounding Pharmacy: The Past Decade	Vol. 10 No. 1	6
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh	Vol. 10 No. 1	9
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery	Vol. 10 No. 1	14
Pharmaceutical Legislation: An Historical Perspective	Vol. 10 No. 1	20
Pharmacy Compounding Urban Legends	Vol. 10 No. 1	32
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations	Vol. 10 No. 1	36
Quality Control Analytical Methods: Common Concerns about Out-of-Specification Results	Vol. 10 No. 1	41
Acacia and Mineral Oil Emulsion NF	Vol. 10 No. 1	44
How'd They Do That?	Vol. 10 No. 1	46
Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success	Vol. 10 No. 1	50
Standard Operating Procedure: Shipping of Prescriptions	Vol. 10 No. 1	56
Calculations	Vol. 10 No. 1	58
Chlorambucil 2-mg/mL Oral Liquid	Vol. 10 No. 1	59
Dantrolene Sodium 5-mg/mL Oral Liquid	Vol. 10 No. 1	60
Domperidone 1-mg/mL Oral Liquid	Vol. 10 No. 1	61
Efavirenz 20-mg/mL Oral Liquid, Anhydrous	Vol. 10 No. 1	62
Medium-Chain Triglycerides Oral Vehicle, Anhydrous	Vol. 10 No. 1	63
Mercaptopurine 50-mg/mL Oral Liquid	Vol. 10 No. 1	64
Misoprostol 1-mg Suppository	Vol. 10 No. 1	65
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid	Vol. 10 No. 1	66
Propylthiouracil 5-mg/mL Oral Liquid	Vol. 10 No. 1	67
Thioguanine 40-mg/mL Oral Liquid	Vol. 10 No. 1	68
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management	Vol. 10 No. 1	69
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds	Vol. 10 No. 1	74
Scientific and Professional Reviewers for 2005	Vol. 10 No. 1	79
PostScription: Stopping Drug Reps at the Door	Vol. 10 No. 1	80
PreScription: The Squeaky Wheel Gets the Grease!	Vol. 10 No. 2	82
Erratum: Allen LV Jr. Lidocaine hydrochloride 2%, misoprostol 0.0024%, and phenytoin 2% topical wound powder. IJPC 2004; 8(4): 298	Vol. 10 No. 2	82
Compounding Pharmacy: The Past Decade, Part 2 -- Equipment Advances	Vol. 10 No. 2	86
Hospice from a Compounding Pharmacist's Perspective	Vol. 10 No. 2	89
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient	Vol. 10 No. 2	95
The Story of Hospice	Vol. 10 No. 2	100
The Dying Process	Vol. 10 No. 2	103
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives	Vol. 10 No. 2	107
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist	Vol. 10 No. 2	113
Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations	Vol. 10 No. 2	122
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1	Vol. 10 No. 2	128
Standard Operating Procedure: Labconco Basic 47 Laboratory Hood	Vol. 10 No. 2	135
Calculations	Vol. 10 No. 2	136
Amlodipine 1-mg/mL Oral Liquid	Vol. 10 No. 2	137
Chloroquine Phosphate 15-mg/mL Oral Liquid	Vol. 10 No. 2	138
Cimetidine 60-mg/mL Oral Liquid, Alcohol Free	Vol. 10 No. 2	139
Disopyramide Phosphate 1-mg/mL Oral Liquid	Vol. 10 No. 2	140
Mycophenolate Mofetil 50-mg/mL Oral Liquid	Vol. 10 No. 2	141
Norfloxacin 20-mg/mL Oral Liquid	Vol. 10 No. 2	142
Saquinavir 60-mg/mL Oral Liquid	Vol. 10 No. 2	143
Sotalol Hydrochloride 5-mg/mL Oral Liquid	Vol. 10 No. 2	144
Terbinafine Hydrochloride 25-mg/mL Oral Liquid	Vol. 10 No. 2	145
Trazodone Hydrochloride 10-mg/mL Oral Liquid	Vol. 10 No. 2	146
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis	Vol. 10 No. 2	147
Chemical Stability of Diclofenac Sodium Injection	Vol. 10 No. 2	154
Extended Stability of Oxytocin in Common Infusion Solutions	Vol. 10 No. 2	156
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol	Vol. 10 No. 2	159
PreScription: Standards, Legal Standards, and Accreditation	Vol. 10 No. 3	162
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate	Vol. 10 No. 3	165
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor	Vol. 10 No. 3	172
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States	Vol. 10 No. 3	175
Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update	Vol. 10 No. 3	187
Probiotic Therapy, Part 2: Clinical Perspectives	Vol. 10 No. 3	195
Quick Tips for Managing Market Directors	Vol. 10 No. 3	201
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?	Vol. 10 No. 3	202
Basics of Compounding for Dentistry, Part 2: Tooth Whitening	Vol. 10 No. 3	205
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2	Vol. 10 No. 3	208
Wise Buys: Choosing the Right Software for a Compounding Pharmacy	Vol. 10 No. 3	213
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions	Vol. 10 No. 3	218
Calculations	Vol. 10 No. 3	219
Carvedilol 1.25-mg/mL Oral Suspension	Vol. 10 No. 3	220
Enalapril Maleate 1-mg/mL Oral Suspension	Vol. 10 No. 3	221
Granisetron 0.05-mg/mL Oral Suspension	Vol. 10 No. 3	222
Lamotrigine 1-mg/mL Oral Suspension	Vol. 10 No. 3	223
Mesna 20-mg/mL Syrup	Vol. 10 No. 3	224
Mexiletine Hydrochloride 10-mg/mL Oral Suspension	Vol. 10 No. 3	225
Pyrimethamine 2-mg/mL Oral Suspension	Vol. 10 No. 3	226
Quinapril 1-mg/mL Oral Liquid	Vol. 10 No. 3	227
Theophylline 5-mg/mL Oral Liquid, Alcohol-Free	Vol. 10 No. 3	228
Triamcinolone Acetonide 0.1% Mouthwash Solution	Vol. 10 No. 3	229
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration	Vol. 10 No. 3	230
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration	Vol. 10 No. 3	234
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together	Vol. 10 No. 3	237
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk!	Vol. 10 No. 3	240
PreScription: 6-Year or 7-Year Program?	Vol. 10 No. 4	242
Introduction to Hospital Compounding	Vol. 10 No. 4	245
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations	Vol. 10 No. 4	253
Putting the Science Back into the "Art and Science" of Compounding	Vol. 10 No. 4	263
Compounded Treatment Options for Cystitis and Other Bladder Problems	Vol. 10 No. 4	270
Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces	Vol. 10 No. 4	277
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist	Vol. 10 No. 4	281
What are You Willing to Do?	Vol. 10 No. 4	287
Hospice Symptom Relief Kit: An Update	Vol. 10 No. 4	288
Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight	Vol. 10 No. 4	291
Aseptic Compounding in New Zealand and the Use of Still Air Boxes	Vol. 10 No. 4	293
Standard Operating Procedure: Testing of Water Supply: Barnstead D4751 High Purity Water System	Vol. 10 No. 4	296
Calculations	Vol. 10 No. 4	298
Adderall 1-mg/mL Oral Liquid	Vol. 10 No. 4	299
Dapsone 2-mg/mL Oral Liquid	Vol. 10 No. 4	300
Itraconazole 40-mg/mL Oral Liquid	Vol. 10 No. 4	301
Lisinopril 1-mg/mL Oral Liquid	Vol. 10 No. 4	302
Nifedipine 4-mg/mL Oral Liquid	Vol. 10 No. 4	303
Propranolol Hydrochloride 1-mg/mL Oral Liquid	Vol. 10 No. 4	304
Rifabutin 20-mg/mL Oral Liquid	Vol. 10 No. 4	305
Sildenafil Citrate 2.5-mg/mL Oral Liquid	Vol. 10 No. 4	306
Tramadol Hydrochloride 5-mg/mL Oral Liquid	Vol. 10 No. 4	307
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid	Vol. 10 No. 4	308
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729>	Vol. 10 No. 4	309
Stability of Memantine in an Extemporaneously Prepared Oral Liquid	Vol. 10 No. 4	316
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free	Vol. 10 No. 4	318
PostScription: Patients or Clients?	Vol. 10 No. 4	320
PreScription: Certification and Accreditation	Vol. 10 No. 5	322
Topical Cidofovir for Treatment of Resistant Viral Infections	Vol. 10 No. 5	324
Mesotherapy: Cosmetic Applications	Vol. 10 No. 5	331
Dermatological Effects from Years in the Sun: Compounding Opportunities	Vol. 10 No. 5	336
Migraine: A General Approach to Prevention and Treatment	Vol. 10 No. 5	344
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches	Vol. 10 No. 5	351
University of North Carolina at Chapel Hill School of Pharmacy Pharmaceutical Care Laboratories: Compounding Laboratory Curriculum and Renovation	Vol. 10 No. 5	353
Education, Training, and Evaluation of Hospital Compounding Personnel	Vol. 10 No. 5	361
MEDLINE: A Valuable Research Tool for the Compounding Pharmacist	Vol. 10 No. 5	369
Quality-Control Analytical Methods: Sterility Failure Investigations	Vol. 10 No. 5	372
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction	Vol. 10 No. 5	377
Calculations	Vol. 10 No. 5	380
Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations	Vol. 10 No. 5	381
Famotidine 8-mg/mL Oral Liquid	Vol. 10 No. 5	382
Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration	Vol. 10 No. 5	383
Hydroxyurea 100 mg/mL	Vol. 10 No. 5	384
Indinavir 10-mg/mL Oral Liquid	Vol. 10 No. 5	385
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid	Vol. 10 No. 5	386
Midazolam Hydrochloride 1-mg/mL Oral Liquid	Vol. 10 No. 5	387
Nitrazepam 1-mg/mL Oral Liquid	Vol. 10 No. 5	388
Omeprazole 2-mg/mL Oral Liquid	Vol. 10 No. 5	389
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)	Vol. 10 No. 5	390
Pantoprazole Sodium 2-mg/mL Oral Liquid	Vol. 10 No. 5	391
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel	Vol. 10 No. 5	392
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions	Vol. 10 No. 5	396
PostScription: Moving Pharmacy Compounding into the 21st Century and Beyond	Vol. 10 No. 5	400
PreScription: International Journal of Pharmaceutical Compounding is Expanding	Vol. 10 No. 6	402
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals	Vol. 10 No. 6	405
Compounding for Feline Herpetic Keratitis	Vol. 10 No. 6	411
Compounding for Veterinary Medicine	Vol. 10 No. 6	417
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety	Vol. 10 No. 6	418
Taurine for the Treatment of Canine Dilated Cardiomyopathy	Vol. 10 No. 6	421
Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard)	Vol. 10 No. 6	426
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle	Vol. 10 No. 6	428
Ronidazole in the Treatment of Trichomonad Infections in Cats	Vol. 10 No. 6	434
Equipment, Supplies, and Facilities Required for Hospital Compounding	Vol. 10 No. 6	436
Quality Control Analytical Methods: Continuous Quality Improvement	Vol. 10 No. 6	442
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination	Vol. 10 No. 6	446
Calculations: Compounding for Large and Small Animals	Vol. 10 No. 6	449
Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies	Vol. 10 No. 6	450
Amiloride Hydrochloride 1-mg/mL Oral Liquid	Vol. 10 No. 6	452
Chloral Hydrate 50-mg/mL Oral Liquid	Vol. 10 No. 6	453
Cyclophosphamide 2-mg/mL Oral Liquid	Vol. 10 No. 6	454
Disulfiram 25-mg/mL Oral Liquid	Vol. 10 No. 6	455
Gabapentin 100-mg/mL Oral Liquid	Vol. 10 No. 6	456
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid	Vol. 10 No. 6	457
Indomethacin 2-mg/mL Oral Liquid	Vol. 10 No. 6	458
Naltrexone 1-mg/mL Oral Liquid	Vol. 10 No. 6	459
Terbutaline Sulfate 1-mg/mL Oral Liquid	Vol. 10 No. 6	460
Valacyclovir 50-mg/mL Oral Liquid	Vol. 10 No. 6	461
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists	Vol. 10 No. 6	462
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations	Vol. 10 No. 6	469
PostScription: Challenges Facing an Analytical Laboratory	Vol. 10 No. 6	479